RRMM
FDA Approves Pepaxto for Triple-Refractory Multiple Myeloma
The FDA granted accelerated approval to melphalan flufenamide (Pepaxto, Oncopeptides AB) in combination with ...
MARCH 5, 2021
New Monoclonal Antibody Approved to Treat Relapsed/Refractory MM
The FDA approved isatuximab-irfc (Sarclisa, Sanofi) in combination with pomalidomide (Pomalyst, Celgene) and ...
MARCH 3, 2020
Load more